Editorial: Polymorphisms in CYP11B genes and 11-hydroxylase activity

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 2, 2005, Pages 1252-1255

  White, Perrin C ^a   Rainey, William E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; ANGIOTENSIN; CORTICOTROPIN; DEOXYCORTICOSTERONE; POTASSIUM; RENIN; TRANSCRIPTION FACTOR;

ADRENAL GLAND; ALDOSTERONE RELEASE; CONGENITAL ADRENAL HYPERPLASIA; CYP11B1 GENE; CYP11B2 GENE; DNA POLYMORPHISM; EDITORIAL; ENZYME ACTIVITY; ENZYME POLYMORPHISM; GENE; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; PRIORITY JOURNAL; STEROID 21 MONOOXYGENASE DEFICIENCY;

ALDOSTERONE SYNTHASE; HUMANS; MUTATION; POLYMORPHISM, GENETIC; STEROID 11-BETA-HYDROXYLASE;

EID: 14044262355     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-2452     Document Type: Editorial

References (40)

1. White PC, Curnow KM, Pascoe L 1994 Disorders of steroid 11β hydroxylase isozymes. Endocr Rev 15:421-438
2. Curnow KM, Slutsker L, Vitek J, Cole T, Speiser PW, New MI, White PC, Pascoe L 1993 Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension duster in exons 6, 7, and 8. Proc Natl Acad Sci USA 90:4552-4556
3. Pascoe L, Curnow KM, Slutsker L, Rosler A, White PC 1992 Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyloxidase II deficiency. Proc Natl Acad Sci USA 89:4996-5000
4. Lifton RP, Dluhy RG, Powers M, Rich GM, Gutkin M, Fallo F, Gill Jr JR, Feld L, Ganguly A, Laidlaw JC, Murnaghan DJ, Kaufman C, Stockigt JR, Ulick S, Lalouel JM 1992 Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nat Genet 2:66-74
5. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel JM 1992 A chimaeric 11β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355:262-265
6. Pascoe L, Curnow KM, Slutsker L, Connell JM, Speiser PW, New MI, White PC 1992 Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2. Proc Natl Acad Sci USA 89:8327-8331
7. White PC, Speiser PW 2000 Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 21:245-291
8. Johrer K, Geley S, Strasser-Wozak EM, Azziz R, Wollmann HA, Schmitt K, Kofler R, White PC 1997 CYP11B1 mutations causing nonclassic adrenal hyperplasia due to 11β-hydroxylase deficiency. Hum Mol Genet 6:1829-1834
9. Zhang G, Rodriguez H, Fardella CE, Harris DA, Miller WL 1995 Mutation T318M in the CYP11B2 gene encoding P450c11AS (aldosterone synthase) causes corticosterone methyl oxidase II deficiency. Am J Hum Genet 57:1037-1043
10. White PC, Slutsker L 1995 Haplotype analysis of CYP11B2. Endocr Res 21:437-442
11. Bassett MH, Zhang Y, Clyne C, White PC, Rainey WE 2002 Differential regulation of aldosterone synthase and 11β-hydroxylase transcription by steroidogenic factor-1. J Mol Endocrinol 28:125-135
12. Clyne CD, Zhang Y, Slutsker L, Mathis JM, White PC, Rainey WE 1997 Angiotensin II and potassium regulate human CYP11B2 transcription through common cis elements. Mol Endocrinol 11:638-649
13. Kupari M, Hautanen A, Lankinen L, Koskinen P, Virolainen J, Nikkila H, White PC 1998 Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass and function. Circulation 97:569-575
14. Schunkert H, Hengstenberg C, Holmer SR, Broeckel U, Luchner A, Muscholl MW, Kurzinger S, Doring A, Hense HW, Riegger GA 1999 Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure. Circulation 99:2255-2260
15. Mulatero P, Schiavone D, Fallo F, Rabbia F, Pilon C, Chiandussi L, Pascoe L, Veglio F 2000 CYP11B2 gene polymorphisms in idiopathic hyperaldosteronism. Hypertension 35:694-698
16. Patel S, Steeds R, Channer K, Samani NJ 2000 Analysis of promoter region polymorphism in the aldosterone synthase gene (CYP11B2) as a risk factor for myocardial infarction. Am J Hypertens 13:134-139
17. Tsujita Y, Iwai N, Katsuya T, Higaki J, Ogihara T, Tamaki S, Kinoshita M, Mannami T, Ogata J, Baba S 2001 Lack of association between generic polymorphism of CYP11B2 and hypertension in Japanese: the Suita Study. Hypertens Res 24:105-109
18. Payne JR, Dhamrait SS, Toor IS, Cooper J, Jones A, Miller GJ, Humphries SE, Montgomery HE 2004 The -344T>C promoter variant of the gene for aldosterone synthase (CYP11B2) is not associated with cardiovascular risk in a prospective study of UK healthy men. Atherosclerosis 174:81-86
19. Benetos A, Poirier O, Guyene TT, Gautier S, Pojoga L, Cambien F 1997 Genetic determination of plasma aldosterone levels. Hypertension 30:493 (Abstract)
20. Tamaki S, Iwai N, Tsujita Y, Kinoshita M 1999 Genetic polymorphism of CYP11B2 gene and hypertension in Japanese. Hypertension 33:266-270
21. Fardella CE, Rodriguez H, Montera J, Zhang G, Vignolo P, Rojas A, Villarroel L, Miller WL 1996 Genetic variation in P450c11 AS in Chilean patients with low renin hypertension. J Clin Endocrinol Metab 81:4347-4351
22. Brand E, Chatelain N, Mulatero P, Fery I, Curnow KM, Jeunemaitre X, Corvol P, Pascoe L, Soubrier F 1998 Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension 32:198-204
23. Davies E, Holloway CD, Ingram MC, Inglis GC, Friel EC, Morrison C, Anderson NH, Fraser R, Connell JM 1999 Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension 33:703-707
24. Komiya I, Yamada T, Takara M, Asawa T, Shimabukuro M, Nishimori T, Takasu N 2000 Lys(173)Arg and -344T/C variants of CYP11B2 in Japanese patients with low-renin hypertension. Hypertension 35:699-703
25. Staessen JA, Wang JG, Brand E, Barlassina C, Birkenhager WH, Herrmann SM, Fagard R, Tizzoni L, Bianchi G 2001 Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens 19:1349-1358
26. Russo P, Siani A, Venezia A, Iacone R, Russo O, Barba G, D'Elia L, Cappuccio FP, Strazzullo P 2002 Interaction between the C(-344)T polymorphism of CYP11B2 and age in the regulation of blood pressure and plasma aldosterone levels: cross-sectional and longitudinal findings of the Olivetti Prospective Heart Study. J Hypertens 20:1785-1792
27. Zhu H, Sagnella GA, Dong Y, Miller MA, Onipinla A, Markandu ND, MacGregor GA 2003 Contrasting associations between aldosterone synthase gene polymorphisms and essential hypertension in blacks and in whites. J Hypertens 21:87-95
28. Barbato A, Russo P, Siani A, Folkerd EJ, Miller MA, Venezia A, Grimaldi C, Strazzullo P, Cappuccio FP 2004 Aldosterone synthase gene (CYP11B2) C-344T polymorphism, plasma aldosterone, renin activity and blood pressure in a multi-ethnic population. J Hypertens 22:1895-1901
29. Delles C, Erdmann J, Jacobi J, Hilgers KF, Fleck E, Regitz-Zagrosek V, Schmieder RE 2001 Aldosterone synthase (CYP11B2) -344 C/T polymorphism is associated with left ventricular structure in human arterial hypertension. J Am Coll Cardiol 37:878-884
30. Ylitalo A, Airaksinen KEJ, Hautanen A, Kupari M, Carson M, Virolainen J, Savolainen MJ, Kauma H, Kesaniemi A, White PC, Huikari H 2000 Baroreflex sensitivity and variants of the renin angiotensin system genes. J Am Coll Cardiol 35:194-200
31. Hautanen A, Toivanen P, Manttari M, Tenkanen L, Kupari M, Manninen V, Kayes KM, Rosenfeld S, White PC 1999 Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction. Circulation 100:2213-2218
32. Hengstenberg C, Holmer SR, Mayer B, Lowel H, Engel S, Hense HW, Riegger GA, Schunkert H 2000 Evaluation of the aldosterone synthase (CYP11B2) gene polymorphism in patients with myocardial infarction. Hypertension 35:704-709
33. Matsubara M, Omori F, Fujita S, Metoki H, Kikuya M, Fujiwara T, Araki T, Imai Y 2001 Haplotypes of aldosterone synthase (CYP11B2) gene in the general population of Japan: the Ohasama study. Clin Exp Hypertens 23:603-610
34. Hautanena A, Lankinen L, Kupari M, Janne OA, Adlercreutz H, Nikkila H, White PC 1998 Associations between aldosterone synthase gene polymorphism and the adrenocortical function in males. J Intern Med 244:11-18
35. Davies E, Holloway CD, Ingram MC, Friel EC, Inglis GC, Swan L, Hillis WS, Fraser R, Connell JM 2001 An influence of variation in the aldosterone synthase gene (CYP11B2) on corricosteroid responses to ACTH in normal human subjects. Clin Endocrinol (Oxf) 54:813-817
36. Keavney B, Mayosi B, Gaukrodger N, Imrie H, Baker M, Fraser R, Ingram M, Watkins H, Farrall M, Davies E, Connell J 2005 Generic variation at the locus encompassing 11-β hydroxylase and aldosterone synthase accounts for heritability in cortisol precursor (11-deoxycortisol) urinary metabolite excretion. J Clin Endocrinol Metab 90:1072-1077
37. Ganapathipillai S, Lavai G, Hoffmann IS, Castejon AM, Nicod J, Dick B, Frey FJ, Frey BM, Cubeddu LX, Ferrari P 2005 CYP11B2-CYP11B1 haplotypes associated with decreased 11β-hydroxylase activity. J Clin Endocrinol Metab 90:1220-1225
38. Kennon B, Ingram MC, Friel EC, Anderson NH, MacKenzie SM, Davies E, Shakerdi L, Wallace AM, Fraser R, Connell JM 2004 Aldosterone synthase gene variation and adrenocortical response to sodium status, angiotensin II and ACTH in normal male subjects. Clin Endocrinol (Oxf) 61:174-181
39. Connell JM, Fraser R, MacKenzie SM, Friel EC, Ingram MC, Holloway CD, Davies E 2004 The impact of polymorphisms in the gene encoding aldosterone synthase (CYP11B2) on steroid synthesis and blood pressure regulation. Mol Cell Endocrinol 217:243-247
40. Oelkers W 1985 Prolonged ACTH infusion suppresses aldosterone secretion in spite of high renin activity. Acta Endocrinol (Copenh) 108:91-97